Prostate Anticancer Activity Testing α Mangostin Invitro Study on Sel DU 145 Using WST 8 Method

Authors

Rai Chika Dewi , Syafika Alaydrus , Tien Wahyuhandayani

DOI:

10.29303/jppipa.v10i8.8517

Published:

2024-08-31

Issue:

Vol. 10 No. 8 (2024): August

Keywords:

α- mangostin, Cisplatin, Prostate cancer

Research Articles

Downloads

How to Cite

Dewi, R. C., Alaydrus, S., & Wahyuhandayani, T. (2024). Prostate Anticancer Activity Testing α Mangostin Invitro Study on Sel DU 145 Using WST 8 Method. Jurnal Penelitian Pendidikan IPA, 10(8), 5851–5855. https://doi.org/10.29303/jppipa.v10i8.8517

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Abstract

Prostate cancer is a cancer that has a high risk of death. Prostate cancer, specifically prostate adenocarcinoma, arises from the cells in the prostate gland or its peripheral zone. Chemotherapy, radiation therapy, and surgery are the main treatments for prostate cancer today. Empirical evidence shows that α-mangostin is used as a cancer therapy. At every stage of carcinogenesis, including cell division, proliferation, apoptosis, inflammation, and metastasis, α-mangostin can inhibit it. This study aims to evaluate the activity of α-mangostin against the DU145 prostate cancer cell line, and compare the %survival rate between cisplatin and α-mangostin. The method used is cytotoxicity testing in vitro with the WST-8 method. The research results showed that α-mangostin had an IC50 value of 16.89 ppm, in the active category, IC50 of cisplatin was 4.69 in the active category. Then statistical analysis was carried out using GraphPad Prism versi9.0.0 The results obtained were no significant differences between %survival rate cisplatin and α-mangostin at a concentration of 12.5 ppm. The conclusion of this study is The IC50 values of α-Mangostin and cisplatin against DU 145 cells were 16.89 ppm and 4.65 ppm, respectively. At a concentration of 12.5 ppm, there was no significant difference in their effects.

References

Andriese, N. P. S. A. S. A., Santoso, P., Ari Candra, A., & Surya Rahadi, I. W. (2023). Studi Bioinformatika Kandungan Curzerene Pada Daun Dewandaru (Eugenia uniflora Linn.) Sebagai Antikanker Prostate Melalui Pensinyalan PI3K. Usadha, 2(2), 31–38. https://doi.org/10.36733/usadha.v2i2.6733

Barba-Ostria, C., Carrera-Pacheco, S. E., Gonzalez-Pastor, R., Heredia-Moya, J., Mayorga-Ramos, A., Rodriguez-Pólit, C., Zúñiga-Miranda, J., Arias-Almeida, B., & Guamán, L. P. (2022). Evaluation of biological activity of natural compounds: current trends and methods. Molecules, 27(14), 4490. https://doi.org/10.3390/molecules27144490

Brown, A., Kumar, S., & Tchounwou, P. B. (2019). Cisplatin-Based Chemotherapy of Human Cancers. J Cancer Sci Ther, 11(4). https://doi.org/10.18637/jss.v048.i02

Cabasag, C. J., Fagan, P. J., Ferlay, J., Vignat, J., Laversanne, M., Liu, L., van der Aa, M. A., Bray, F., & Soerjomataram, I. (2022). Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020. International Journal of Cancer, 151(9), 1535–1541. https://doi.org/10.1002/ijc.34002

Chen, G., Li, Y., Wang, W., & Deng, L. (2018). Bioactivity and pharmacological properties of α-mangostin from the mangosteen fruit: a review. Expert Opinion on Therapeutic Patents, 28(ue 5), 415–427. https://doi.org/10.1080/13543776.2018.1455829

Dasari, S., & Bernard Tchounwou, P. (2014). Cisplatin in cancer therapy: Molecular mechanisms of action. European Journal of Pharmacology, 740, 364–378. https://doi.org/10.1016/j.ejphar.2014.07.025

Gao, F., Huang, G., & Xiao, J. (2020). Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure-activity relationship. Medicinal Research Reviews, 40(5), 2049–2084. https://doi.org/10.1002/med.21698

Johnson, J. J., Petiwala, S. M., Syed, D. N., Rasmussen, J. T., Adhami, V. M., Siddiqui, I. A., Kohl, A. M., & Mukhtar, H. (2012). α-mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth. Carcinogenesis, 33(2), 413–419. https://doi.org/10.1093/carcin/bgr291

Kamijima, T., Yaegashi, H., Mizokami, A., Nakajima, K., Matsuyama, H., & Ichikawa, T. (2022). Efficacy of Androgen Receptor-targeted Drugs After Prostate Cancer Recurrence with Bone Metastases: PROSTAT-BSI Sub-analysis. Anticancer Res, 42(6), 30993108. https://doi.org/10.21873/anticanres.15798

Khan, M., Hearn, K., Parry, C., Rashid, M., Brim, H., Ashktorab, H., & Kwabi-Addo, B. (2023). Mechanism of antitumor effects of saffron in human prostate cancer cells. Nutrients, 16(1), 114. https://doi.org/10.3390/nu16010114

Khelifi, I., Hayouni, E. A., Cazaux, S., Ksouri, R., & Bouajila, J. (2020). Evaluation of in vitro biological activities: antioxidant; anti-inflammatory; anti-cholinesterase; anti-xanthine oxidase, anti-superoxyde dismutase, anti-Î$pm$-glucosidase and cytotoxic of 19 bioflavonoids. Cellular and Molecular Biology, 66(1), 9–19. Retrieved from http://cellmolbiol.org/index.php/CMB/article/view/2591

Kim, S. M., Han, J. M., Le, T. T., Sohng, J. K., & Jung, H. J. (2020). Anticancer and antiangiogenic activities of novel α-mangostin glycosides in human hepatocellular carcinoma cells via downregulation of c-Met and HIF-1α. International Journal of Molecular Sciences, 21(11), 4043. https://doi.org/10.3390/ijms21114043

Meylina, L., Muchtaridi, M., Joni, I. M., Mohammed, A. F. A., & Wathoni, N. (2021). Nanoformulations of α-mangostin for cancer drug delivery system. Pharmaceutics, 13(12), 1993. https://doi.org/10.3390/pharmaceutics13121993

Muchtaridi, M., & Wijaya, C. A. (2017). Anticancer potential of α-mangostin. Asian Journal of Pharmaceutical and Clinical Research, 10(12). https://doi.org/10.22159/ajpcr.2017.v10i12.20812

Murtaza, I., Rashid, N., Laila, O., Ganie, N. A., & Wani, M. Y. (2020). Anti-cancer and anti-microbial potential of nutraceutical rich under utilized herb Portulaca oleracea from Kashmir region. Int J Curr Microbiol App Sci, 9, 3496–3508. https://doi.org/10.20546/ijcmas.2020.909.434

Nauman, M. C., & Johnson, J. J. (2022). The purple mangosteen (Garcinia mangostana): Defining the anticancer potential of selected xanthones. Pharmacol Res, 175. https://doi.org/10.1016/j.phrs.2021.106032

Ogbonna, C., & Özgör, E. (2021). Detection of Biological Activity of Methanol Extract and Its Antibacterial effect on. The EuroBiotech Journal, 5(2), 56–62. Retrieved from https://sciendo.com/article/10.2478/ebtj-2021-0009

Patil, P., Agrawal, M., Almelkar, S., Jeengar, M. K., More, A., Alagarasu, K., Kumar, N. V, Mainkar, P. S., Parashar, D., & Cherian, S. (2021). In vitro and in vivo studies reveal α-Mangostin, a xanthonoid from Garcinia mangostana, as a promising natural antiviral compound against chikungunya virus. Virology Journal, 18(1). https://doi.org/10.1186/s12985-021-01517-z

Rusdin, A. (2019). α-Mangostin dari Buah Manggis, Kandidat Obat Antikanker Baru. Farmasetika, 3(2). https://doi.org/10.24198/farmasetika.v4i2.22533

Russell, P. J., & Kingsley, E. A. (2003). Human prostate cancer cell lines. Prostate Cancer Methods and Protocols, 21–39. https://doi.org/10.1385/1-59259-372-0:21

Shibata, M. A., Iinuma, M., Morimoto, J., Kurose, H., Akamatsu, K., Okuno, Y., Akao, Y., & Otsuki, Y. (2011). α-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation. BMC Medicine, 9. https://doi.org/10.1186/1741-7015-9-69

Vien, L. C., Chinnappan, S., & Mogana, R. (2021). Antioxidant activity of garcinia mangostana l and alpha mangostin: A review. Res J Pharm Technol, 14(8). Retrieved from https://www.indianjournals.com/ijor.aspx?target=ijor:rjpt&volume=14&issue=8&article=082

Wathoni, N., Rusdin, A., Motoyama, K., Joni, I. M., Lesmana, R., & Muchtaridi, M. (2020). Nanoparticle drug delivery systems for α-mangostin. In Nanotechnology, Science and Applications (Vol. 13, pp. 23–36). Dove Medical Press Ltd. https://doi.org/10.2147/NSA.S243017

Zhang, H., Tan, Y., Zhao, L., Wang, L., Fu, N., Zheng, S., & Shen, X. (2020). Anticancer activity of dietary xanthone $α$-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1. Cell Death & Disease, 11(1), 63. Retrieved from https://www.nature.com/articles/s41419-020-2227-4

Zhong, G.-C., Li, Z., You, A.-J., Zhu, Q., Wang, C.-R., & Yang, P.-F. (2023). Plant-based diets and the risk of pancreatic cancer: a large prospective multicenter study. The American Journal of Clinical Nutrition, 117(2), 235–242. https://doi.org/10.1016/j.ajcnut.2022.11.013

Zhu, W., Li, Y., & Gao, L. (2015). Cisplatin in combination with programmed cell death protein 5 increases antitumor activity in prostate cancer cells by promoting apoptosis. Molecular Medicine Reports, 11(6), 4561–4566. https://doi.org/10.3892/mmr.2015.3252

Author Biographies

Rai Chika Dewi, Sekolah Tinggi ILmu Farmasi Pelita Mas Palu

Syafika Alaydrus, STIFA Pelita Mas Palu

Tien Wahyuhandayani, STIFA Pelita Mas Palu, Central Sulawesi

License

Copyright (c) 2024 Rai Chika Dewi, Syafika Alaydrus, Tien Wahyuhandayani

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with Jurnal Penelitian Pendidikan IPA, agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, web sites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Jurnal Penelitian Pendidikan IPA.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).